Company Profile
Updated: 28-SEP-09Haematologic Technologies Inc.
Private Company, Headquarters Location
57 River Rd., Ste. 1021, Essex Junction, VT 05452-3842, United States
(802)878-1777, (802)878-1776 fax, http://www.haemtech.com
Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Manufacturer of coagulation proteins and research reagents including purified plasma zymogens, enzymes, cofactors, inhibitors, substrates, antibodies, sample collection tubes and ELISA reagents.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Mesoblast Limited (ASX:MSB) Successful Bone Marrow Regeneration In Cancer Patients Using Cord Blood Expanded By Proprietary Stem Cells
abnnewswire.net; 11/6/2009; 871 words; ...Angioblast Systems Inc. is conducting the...critically ill patients with haematologic malignancies following...numbers in patients with haematologic malignancies. In view...to commercialise the technology in as short a timeframe...series of patents and technologies that have been ...
Mesoblast Limited's (ASX:MSB) First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment
abnnewswire.net; 6/24/2009; 814 words; ...five patients with haematologic malignancies who...Angioblast Systems Inc. for expanding...in patients with haematologic malignancies...ill patients with haematologic malignancies following...commercialise the technology in as short a timeframe...of patents and technologies that have ...
Mesoblast Limited (ASX:MSB) Emerging Portfolio of Clinical Products Underpin Commercial Strategic Objectives
abnnewswire.net; 2/26/2009; 1021 words; ...Angioblast Systems Inc; areas of development...treat patients with haematologic malignancies who need...to commercialise the technology in as short a timeframe...series of patents and technologies that have been developed...Angioblast Systems Inc, an American company...developing the ...
New transplantation study findings have been reported from V. Borrill et al.
Blood Weekly; 12/11/2008; 871 words; ...assay to serially characterise the haematologic course and so evaluate the usefulness...profile. To illustrate the ability of this technology, three representative profiles are described...Africa, Cape Town, Applied Biosystems Inc., Biological Therapy, Biosystems Ltd...
Mesoblast Limited (ASX:MSB) Bone Marrow Transplant Trial Receives US FDA Clearance
abnnewswire.net; 11/5/2008; 1106 words; ...to 30 patients with haematologic malignancies undergoing...Angioblast Systems Inc. for treating patients with haematologic malignancies requiring...For patients with haematologic malignancies, transplantation...commercialise the technology in as short a timeframe...series of patents and ...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
Related Company Profiles
- Hebei Yiheng Group Company Ltd.
- Hebei Yiling Pharmaceutical Group
- Shandong Zhenxing Group General Corp.